(Q37321018)

19 August 2017

1 reference

title

Renal tumor natural history: the rationale and role for active surveillance (English)

1 reference

19 August 2017

1 reference

Michael A S Jewett

1

1 reference

19 August 2017

Alvaro Zuniga

series ordinal

2

1 reference

19 August 2017

publication date

1 November 2008

1 reference

Urologic Clinics of North America

19 August 2017

published in

1 reference

19 August 2017

volume

35

1 reference

19 August 2017

issue

4

1 reference

19 August 2017

page(s)

627-34; vii

1 reference

Renal cancer: molecular mechanisms and newer therapeutic options

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

The changing natural history of renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Rising incidence of small renal masses: a need to reassess treatment effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Rising incidence of renal cell cancer in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

RENAL CELL CARCINOMA: PROGNOSTIC SIGNIFICANCE OF INCIDENTALLY DETECTED TUMORS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

The natural history of small renal masses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Increased incidence of serendipitously discovered renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Incidental renal cell carcinoma-age and stage characterization and clinical implications: study of 1092 patients (1982-1997)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Solid renal tumors: an analysis of pathological features related to tumor size

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Five-year survival after surgical treatment for kidney cancer: a population-based competing risk analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Complications of radical and partial nephrectomy in a large contemporary cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

NEPHRON SPARING SURGERY FOR RENAL TUMORS: INDICATIONS, TECHNIQUES AND OUTCOMES

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Nephron sparing surgery in incidental versus suspected renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Conservative management of incidental contrast-enhancing renal masses as safe alternative to invasive therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Progression and survival after renal-conserving surgery for renal cell carcinoma: experience in 104 patients and extended followup

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Nephron-sparing surgery for renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Small renal parenchymal neoplasms: further observations on growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Natural history of renal masses followed expectantly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Growth rates of primary and metastatic lesions of renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

The natural history of incidentally detected small renal masses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Watchful waiting for solid renal masses: insight into the natural history and results of delayed intervention.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Enhancing renal masses with zero net growth during active surveillance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

P53 mutations and other prognostic factors of renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Natural history of small renal cell carcinoma: evaluation of growth rate, histological grade, cell proliferation and apoptosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Management of renal masses in patients medically unsuitable for nephrectomy--natural history, complications, and outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Cystic renal cell carcinoma is cured by resection: a study of 24 cases with long-term followup

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Outcome of surgery in cystic renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Multilocular cystic renal cell carcinoma: a series of 12 cases and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Prognostic Significance of Incidental Renal Cell Carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Incidentally detected renal cell carcinoma: pathological features, survival trends and implications for treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Correlation with clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Observations on the growth rate of renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Using tumor markers to predict the survival of patients with metastatic renal cell carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Cell proliferation, apoptosis, angiogenesis and growth rate of incidentally found renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Prognostic relevance of the mTOR pathway in renal cell carcinoma: implications for molecular patient selection for targeted therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Expression of PTEN in renal cell carcinoma and its relation to tumor behavior and growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Cell proliferation and apoptosis with BCL-2 expression in renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

The p75 NTR neurotrophin receptor is a tumor suppressor in human and murine retinoblastoma development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Polymorphisms of DNA repair genes are associated with renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Gene signatures of progression and metastasis in renal cell cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Gene expression profiling predicts survival in conventional renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

The natural history of untreated renal masses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Renal mass biopsy--a renaissance?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Percutaneous needle biopsy for indeterminate renal masses: a national survey of UK consultant urologists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Prospective evaluation of fine needle aspiration of small, solid renal masses: accuracy and morbidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Diagnostic yield of 58 consecutive imaging-guided biopsies of solid renal masses: should we biopsy all that are indeterminate?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Renal mass core biopsy: accuracy and impact on clinical management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

The accuracy of 250 fine needle biopsies of renal tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Evaluation of fine-needle aspiration cytology for renal masses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Diagnostic value of CT-guided biopsy of indeterminate renal masses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Role of percutaneous image-guided biopsy in the evaluation of renal masses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Fine-needle percutaneous biopsy of renal masses with helical CT guidance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Accuracy and clinical role of fine needle percutaneous biopsy with computerized tomography guidance of small (less than 4.0 cm) renal masses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Accuracy of diagnosis by guided biopsy of renal mass lesions classified indeterminate by imaging studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Incidental renal tumours: the frequency of benign lesions and the role of preoperative core biopsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Selective Renal Tumour Biopsy under Ultrasonic Guidance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Needle tract seeding following aspiration of renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Needle tract seeding after percutaneous renal adenocarcinoma aspiration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Cutaneous Seeding of Renal Carcinoma by Chiba Needle Aspiration Biopsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Contraindications to needle aspiration of a solid renal mass: tumor dissemination by renal needle aspiration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Complications of percutaneous abdominal fine-needle biopsy. Review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Role of fine-needle aspiration biopsy in the assessment of renal masses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Ultrasonically guided fine needle aspiration biopsy of renal masses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Diagnosis of renal cell carcinoma: value of fine-needle aspiration cytology in patients with metastases or contraindications to nephrectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Accuracy of fine needle aspiration in distinguishing subtypes of renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

IMAGING GUIDED BIOPSY OF RENAL MASSES: INDICATIONS, ACCURACY AND IMPACT ON CLINICAL MANAGEMENT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Percutaneous abdominal biopsy: cost-identification analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

Mortality and morbidity after nephrectomy for renal cell carcinoma using a transperitoneal anterior subcostal incision

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UCL.2008.07.004

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.UCL.2008.07.004

1 reference

19 August 2017

1 reference